Home » Markt für die Behandlung der Amyotrophen Lateralsklerose (ALS)

Markt für die Behandlung der Amyotrophen Lateralsklerose (ALS) nach Typ (Sporadische ALS, Familiäre ALS); Nach Medikament (Riluzol, Edaravon, Andere); Nach Vertriebskanal (Krankenhausapotheken, Einzelhandelsapotheken, Andere) – Wachstum, Anteil, Chancen & Wettbewerbsanalyse, 2024 – 2032

Report ID: 201305 | Report Format : Excel, PDF
Kostenloses Muster anfordern

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Fordern Sie Ihren Musterbericht an und starten Sie Ihre Reise zu fundierten Entscheidungen


Bereitstellung des strategischen Kompasses für Branchenriesen.

cr-clients-logos
Häufig gestellte Frage:
Wie groß ist der Markt für ALS-Behandlungen weltweit im Jahr 2023, und wie groß wird er voraussichtlich bis 2032 sein?

Der Markt wurde im Jahr 2024 auf etwa 657,0 Millionen USD geschätzt und wird voraussichtlich bis 2032 1.019,2 Millionen USD erreichen, mit einer jährlichen Wachstumsrate (CAGR) von 5,66 % von 2025 bis 2032.

Welche Region hält den größten Marktanteil bei der ALS-Behandlung?

Nordamerika dominiert den ALS-Behandlungsmarkt aufgrund seiner fortschrittlichen Gesundheitsinfrastruktur, höherer Diagnosequoten und der starken Präsenz wichtiger Pharmaunternehmen.

Was sind die aktuellen Trends, die die ALS-Behandlungslandschaft beeinflussen?

Zu den aufkommenden Trends gehören die Einführung von Gen- und Stammzelltherapien, die erhöhte Nutzung von Biomarkern und die Integration von KI und digitalen Gesundheitswerkzeugen in die Krankheitsüberwachung.

Wer sind die führenden Akteure im Markt für ALS-Behandlungen?

Wichtige Unternehmen, die auf dem Markt tätig sind, sind Mitsubishi Tanabe Pharma, Amylyx Pharmaceuticals, Cytokinetics, BrainStorm Cell Therapeutics und Biogen Inc.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Oral Macromolecular Formulation Market

The Oral Macromolecular Formulation market size was valued at USD 17.5 billion in 2025 and is projected to reach USD 24.5 billion by 2032, reflecting a CAGR of 4.9% during the forecast period.

Ineffective Esophageal Motility Treatment Market

The Ineffective Esophageal Motility Treatment market size was valued at USD 4,680 million in 2024 and is projected to reach USD 7,402.47 million by 2032, growing at a CAGR of 5.9% during the forecast period.

At-Home Molecular Testing Market

At Home Molecular Testing market size was valued at USD 10,809 million in 2024 and is anticipated to reach USD 16,463.2 million by 2032, growing at a CAGR of 5.4% during the forecast period.

OTC Cough Cold And Allergy Medicine Market

The global OTC cough, cold, and allergy medicine market was valued at USD 23,450 million in 2024 and is projected to reach USD 32,590.02 million by 2032, expanding at a compound annual growth rate (CAGR) of 4.2% during the forecast period.

Novel Cardiovascular Drug Delivery Devices Market

Novel Cardiovascular Drug Delivery Devices Market size was valued USD 5189 million in 2024 and is anticipated to reach USD 9322.84 million by 2032, at a CAGR of 7.6% during the forecast period.

Small Molecule Injectable Market

The Small Molecule Injectable market was valued at USD 141,836 million in 2024 and is anticipated to reach USD 241,884.7 million by 2032, growing at a CAGR of 6.9% during the forecast period.

Nanoparticle Formulation Market

Nanoparticle Formulation Market size was valued USD 8589 million in 2024 and is anticipated to reach USD 16863.73 million by 2032, at a CAGR of 8.8% during the forecast period.

Autologous Conditioned Plasma (ACP) Market

Autologous Conditioned Plasma (ACP) Market size was valued USD 584 million in 2024 and is anticipated to reach USD 1366.31 million by 2032, at a CAGR of 11.2% during the forecast period.

Autogenous Vaccine Market

Autogenous Vaccine Market size was valued USD 465 million in 2024 and is anticipated to reach USD 810.46 million by 2032, at a CAGR of 7.2% during the forecast period.

Combination Therapies In Aesthetics Market

The global combination therapies in aesthetics market was valued at USD 3,690 million in 2024 and is projected to reach USD 6,880.69 million by 2032, expanding at a compound annual growth rate (CAGR) of 8.1% during the forecast period.

Antioxidants Market

The global antioxidants market was valued at USD 4,095.8 million in 2024 and is anticipated to reach USD 6,657.29 million by 2032, expanding at a CAGR of 6.26% during the forecast period.

U.S. Pharma R&D Outsourcing Market

US Pharma R&D Outsourcing Market size was valued at USD 30,916.90 Million in 2024 and is anticipated to reach USD 67,782.11 Million by 2032, at a CAGR of 10.31% during the forecast period.

Lizenzoption

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$7999

Report delivery within 24 to 48 hours

Europe

North America

Email

Smallform of Sample request
User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materialwissenschaftler
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Managementassistent, Bekaert

cr-clients-logos

Request Sample